CAND1 Antibody (Rabbit mAb) [B17D18]

CatNo: F9659

    Application: Reactivity:
    • Lane 1: 293T, Lane 2: Hela, Lane 3: Jurkat, Lane 4: Saos-2
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%
    推奨WB希釈率: 1:10000

    使用情報

    Dilution
    1:10000 - 1:50000
    1:40 - 1:60
    1:50 - 1:100
    1:100 - 1:250
    1:20
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    136 kDa
    ポジティブコントロール Human prostatic hyperplasia tissue; 293T cells; HeLa cells; Jurkat cells; Saos-2 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:10000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    CAND1 Antibody (Rabbit mAb) [B17D18] detects endogenous levels of total CAND1 protein.
    タンパク質の局在
    細胞質、細胞核
    Uniprot ID
    Q86VP6
    Clone
    B17D18
    Synonym(s)
    KIAA0829, TIP120, TIP120A, CAND1, Cullin-associated NEDD8-dissociated protein 1, Cullin-associated and neddylation-dissociated protein 1, TBP-interacting protein of 120 kDa A, p120 CAND1, TBP-interacting protein 120A
    Background
    CAND1 (cullin-associated and neddylation-dissociated protein 1) is a large HEAT-repeat scaffold that binds unneddylated cullin–RING cores and dynamically controls the assembly and activity of cullin-RING ubiquitin ligases (CRLs), acting not as a static inhibitor but as a catalytic exchange factor that reshapes the repertoire of substrate receptor modules available for protein ubiquitination. The protein wraps around cullin scaffolds such as CUL1 and CUL2 in a horseshoe-like conformation, with its N‑terminal region occluding the cullin neddylation site and its C‑terminal portion occupying the adaptor-binding interface, thereby preventing simultaneous binding of SKP1–F‑box or other substrate receptor complexes and stabilizing a “core-only” state of the ligase. CAND1 binds preferentially to unneddylated CUL1–Rbx1 and blocks SCF (SKP1–CUL1–F‑box) assembly and activity, but real-time kinetic and quantitative proteomics studies have demonstrated that CAND1 catalytically accelerates F‑box module dissociation and exchange by orders of magnitude once CSN-mediated deneddylation has occurred, driving rapid equilibration of CUL1–Rbx1 cores with diverse SKP1–F‑box pairs and ensuring comprehensive sampling of available substrate receptors. In this adaptive cycle, substrate binding promotes Nedd8 conjugation to CUL1, which displaces CAND1 and stabilizes an active SCF complex until the substrate is ubiquitinated and degraded; subsequent CSN deneddylation reopens the cullin for CAND1 binding, and CAND1 then disassembles the existing adaptor complex and facilitates recruitment of alternative F‑box modules, coupling neddylation status to substrate-receptor turnover and maintaining plasticity in CRL1 signaling. For CUL2-based CRL2^VHL ligases involved in PROTAC target degradation, CAND1 dramatically increases dissociation of CRL2 complexes but only weakly promotes reassembly, thereby inhibiting CRL2-mediated protein degradation and highlighting family- and context-specific effects of CAND1 on distinct CRLs. CAND1 functions as a positive regulator of cullin-containing E3s in vivo, supporting optimal activity of SCF^SLY1^ in gibberellin signaling and cooperating with COP1/COP10 and CUL4 complexes to promote HY5 degradation and repress photomorphogenesis, tuning multiple cullin platforms rather than acting as a simple off-switch. By governing CRL1 composition, CAND1 influences degradation of key regulators in cell-cycle progression, hormone and growth factor pathways, and stress responses, and its dysregulation perturbs normal proteolytic trajectories, affecting metabolic and regenerative phenotypes. In nonalcoholic fatty liver disease, CAND1 is downregulated during hepatic steatosis, enhancing assembly of CUL1–FBXO42–ACAA2 complexes and accelerating ubiquitination and degradation of the mitochondrial β‑oxidation enzyme ACAA2, reducing fatty acid catabolism and promoting lipid accumulation, whereas restoring CAND1 function blocks this assembly and alleviates NAFLD. In adult heart regeneration, elevated CAND1 expression promotes assembly of CUL1–FBXW11–Mob1b complexes and K48-linked ubiquitination of Mob1b, suppressing Hippo signaling and facilitating cardiomyocyte proliferation and repair after myocardial infarction, illustrating how CAND1-directed CRL1 remodeling can be harnessed to manipulate major growth-control pathways. The HEAT-repeat scaffold structure, dual engagement of cullin neddylation and adaptor interfaces, catalytic exchange-factor mechanism, and demonstrated roles in maintaining dynamic CRL repertoires, tuning hormone and light signaling, and modulating Hippo and metabolic pathways position CAND1 as a mechanistically central regulator for ubiquitin-proteasome–based control of signaling, metabolic and regenerative pathologies, and for implementing CRL-targeted interventions.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください